Accounts Payable

9 Months Ended

Sep. 30, 2021

Accounts Payable

Accounts Payable

5.            Accounts Payable

As of September 30, 2021, current liabilities included accounts payable of $0.4 million, comprised primarily of amounts owed for drug supply manufacturing of $0.3 million and legal and patent fees of $0.1 million. As of December 31, 2020, current liabilities included accounts payable of $0.1 million, comprised primarily of investor relations expenses and legal and patent fees of $0.1 million.